Therapeutics in Dermatology
A reference textbook in dermatology


6 June 2012, by DELAPORTE E. & PIETTE F.

Sulfasalazine (Salazopyrin®) was launched in France en 1958. Its current indications are: ulcerative colitis, colic Crohn’s disease and rheumatoid arthritis. This molecule has few uses in a dermatological setting.

× N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!

Follow us


  Health professionals

The other websites of the foundation